MetLife Investment Management LLC Has $115,000 Position in Teleflex Incorporated $TFX

Key Points

• MetLife Investment Management LLC significantly reduced its holdings in Teleflex Incorporated by 93.2%, owning only 835 shares after selling 11,456 during the first quarter.
• Several other institutional investors have increased their stakes in Teleflex, with MassMutual Private Wealth & Trust FSB raising its position by 103.1% during the same period.
• Teleflex reported better-than-expected earnings for the quarter, with $3.73 earnings per share, exceeding the consensus estimate of $3.36 and achieving a 4.2% year-over-year revenue growth.

MetLife Investment Management LLC trimmed its stake in shares of Teleflex Incorporated (NYSE:TFX - Free Report) by 93.2% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 835 shares of the medical technology company's stock after selling 11,456 shares during the period. MetLife Investment Management LLC's holdings in Teleflex were worth $115,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. MassMutual Private Wealth & Trust FSB increased its stake in Teleflex by 103.1% in the 1st quarter. MassMutual Private Wealth & Trust FSB now owns 197 shares of the medical technology company's stock valued at $27,000 after buying an additional 100 shares during the last quarter. Banque Cantonale Vaudoise acquired a new stake in Teleflex in the 1st quarter valued at $27,000. Costello Asset Management INC acquired a new stake in Teleflex in the 1st quarter valued at $28,000. Brooklyn Investment Group increased its stake in Teleflex by 258.6% in the 1st quarter. Brooklyn Investment Group now owns 208 shares of the medical technology company's stock valued at $29,000 after buying an additional 150 shares during the last quarter. Finally, Whipplewood Advisors LLC increased its stake in Teleflex by 7,700.0% in the 1st quarter. Whipplewood Advisors LLC now owns 234 shares of the medical technology company's stock valued at $32,000 after buying an additional 231 shares during the last quarter. 95.62% of the stock is currently owned by institutional investors and hedge funds.

Teleflex Stock Performance

Shares of TFX stock traded down $0.13 during midday trading on Tuesday, hitting $125.76. 407,411 shares of the company were exchanged, compared to its average volume of 608,381. The firm has a market capitalization of $5.56 billion, a P/E ratio of 29.59, a PEG ratio of 1.76 and a beta of 1.08. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.44 and a current ratio of 2.41. The firm's 50 day moving average price is $121.28 and its two-hundred day moving average price is $125.94. Teleflex Incorporated has a 52 week low of $108.90 and a 52 week high of $249.90.

Teleflex (NYSE:TFX - Get Free Report) last announced its earnings results on Thursday, July 31st. The medical technology company reported $3.73 EPS for the quarter, topping the consensus estimate of $3.36 by $0.37. The business had revenue of $780.90 million during the quarter, compared to the consensus estimate of $771.53 million. Teleflex had a net margin of 6.31% and a return on equity of 15.08%. Teleflex's revenue was up 4.2% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $3.42 EPS. Teleflex has set its FY 2025 guidance at 13.900-14.300 EPS. As a group, equities research analysts anticipate that Teleflex Incorporated will post 13.98 earnings per share for the current year.

Teleflex Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, September 15th. Shareholders of record on Friday, August 15th were issued a $0.34 dividend. The ex-dividend date of this dividend was Friday, August 15th. This represents a $1.36 dividend on an annualized basis and a yield of 1.1%. Teleflex's payout ratio is currently 32.00%.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on TFX shares. Mizuho lifted their price target on shares of Teleflex from $130.00 to $135.00 and gave the company a "neutral" rating in a research note on Friday, August 1st. Wells Fargo & Company decreased their price objective on shares of Teleflex from $137.00 to $131.00 and set an "equal weight" rating for the company in a research report on Friday, August 1st. Wall Street Zen downgraded shares of Teleflex from a "strong-buy" rating to a "buy" rating in a research report on Monday. Finally, Royal Bank Of Canada lifted their price objective on shares of Teleflex from $130.00 to $135.00 and gave the company a "sector perform" rating in a research report on Friday, August 1st. One investment analyst has rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company presently has an average rating of "Hold" and a consensus price target of $141.57.

Insider Transactions at Teleflex

In other Teleflex news, Director Stuart A. Randle acquired 1,000 shares of the business's stock in a transaction on Tuesday, August 5th. The stock was purchased at an average price of $115.86 per share, with a total value of $115,860.00. Following the acquisition, the director directly owned 7,547 shares of the company's stock, valued at approximately $874,395.42. This trade represents a 15.27% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Andrew A. Krakauer acquired 1,000 shares of the business's stock in a transaction on Tuesday, August 5th. The stock was acquired at an average cost of $115.25 per share, with a total value of $115,250.00. Following the acquisition, the director directly owned 7,192 shares in the company, valued at approximately $828,878. This trade represents a 16.15% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last ninety days, insiders have purchased 5,500 shares of company stock worth $633,590. Company insiders own 1.40% of the company's stock.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.